Search Results
Found 1 results
510(k) Data Aggregation
(245 days)
ACURA ELITE GRAVITY COMPENSATING RESERVOIR
This device is intended for implantation over either right or left frontal horn, in conjunction with a ventricles for the purpose of diagnostic studies, therapeutic drug access to the cord/or diversion of cerebrospinal fluid.
Accura Elite Gravity Compensating Reservoir
The provided document is a 510(k) premarket notification letter from the FDA for a device called "Acura Elite Gravity Compensating Reservoir." This letter indicates that the device has been found substantially equivalent to a predicate device and can be marketed.
However, the letter does not contain any information about acceptance criteria, device performance studies, sample sizes, expert qualifications, ground truth, or an AI algorithm. This document is a regulatory approval letter, not a scientific study report or clinical trial summary.
Therefore, it is impossible to extract the requested information from the provided text.
Ask a specific question about this device
Page 1 of 1